Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Functional Bioassays

Reporter bioassays and cell health assays are used to characterize and develop novel mAb-based therapeutics. This page includes product listings and examples of how functional bioassays are used throughout biologics drug development workflows. 

Bioassays are available to interrogate the following biological functions:

  • Fc effector activity
  • Immune checkpoint modulation
  • T cell retargeting
  • Cytokine and growth factor signaling
  • Tumor antigen-specific cell killing

In addition to the products listed below, our Assay Development and Services team can provide personalized solutions for your workflow.

A Multipronged Approach to Antibody Therapeutics

Antibody-based therapeutic drugs can be broadly classified into six categories depending on their mechanism of action (MOA), as indicated in the schematic below. Many biologic drugs function via a single mechanism; however, newer drug candidates are being designed that function through multiple mechanisms. The use of MOA-based bioassays to measure the activity of drug candidates is critical throughout the drug development workflow.

Multi pronged approach to Ab therapeutics

Adapted from Weiner, et al. (2015) Nature Reviews Cancer 15, 361–70

Viral Vaccine Development

These publications highlight the use of Promega ADCC and ADCP bioassays in viral vaccine and therapeutic research and development.

Download Publications List

Immunotherapeutic Drug Development

These publications highlight use of Promega reporter bioassays for mAb therapeutics, bispecific antibodies, and other immunotherapy applications.

Download Publications List
Discover new analytical tools for biosimilar development with this free webinar. Learn More.

Filter By

Target Class or Assay Endpoint

Shop Functional Bioassays by Target Class or Biological Endpoint

Showing 36 of 36 Products

Our custom bioassay services can help accelerate your biologic drug development workflow.

Learn More